Announced
Completed
A consortium of investors led a $23.7m Series B round in Mirvie.
Synopsis
A consortium of investors, including Blackrock, Decheng Capital, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield, led a $23.7m Series B round in Mirvie, a biotech company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite